发布求助
文献互助 智能选刊 最新文献

Journal of gastrointestinal and liver diseases : JGLD最新文献

筛选
英文 中文
Case report text-mining and the risk of mistaking reporting trends for clinical history. 病例报告文本挖掘和将报告趋势误认为临床病史的风险。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7482
Hasaan Abdul Rahman, Urooj Akram
{"title":"Case report text-mining and the risk of mistaking reporting trends for clinical history.","authors":"Hasaan Abdul Rahman, Urooj Akram","doi":"10.15403/jgld-7482","DOIUrl":"https://doi.org/10.15403/jgld-7482","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"501-502"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fistula-Associated Mucinous Adenocarcinoma in Crohn's Disease with Multiple Gastrointestinal Metastases. 克罗恩病伴多发性胃肠道转移的瘘管相关粘液腺癌
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6749
Kentaro Kojima, Jun Takada, Takuma Komori, Masahito Shimizu
{"title":"Fistula-Associated Mucinous Adenocarcinoma in Crohn's Disease with Multiple Gastrointestinal Metastases.","authors":"Kentaro Kojima, Jun Takada, Takuma Komori, Masahito Shimizu","doi":"10.15403/jgld-6749","DOIUrl":"https://doi.org/10.15403/jgld-6749","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"324"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatogenic Diabetes Mellitus - Type 3c (T3cDM). 胰源性糖尿病- 3c型（T3cDM）。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7071
David Solil, Petr Dítě, Martina Bojková, Vladimir Kojecký, Jiří Dolina, Bohuslav Kianička
{"title":"Pancreatogenic Diabetes Mellitus - Type 3c (T3cDM).","authors":"David Solil, Petr Dítě, Martina Bojková, Vladimir Kojecký, Jiří Dolina, Bohuslav Kianička","doi":"10.15403/jgld-7071","DOIUrl":"10.15403/jgld-7071","url":null,"abstract":"<p><p>Pancreatogenic diabetes mellitus (type 3c diabetes, T3cDM) is a distinct form of diabetes resulting from primary pancreatic disorders, most commonly chronic pancreatitis. It involves both - endocrine and exocrine dysfunction, leading to unstable glycemia with frequent hypo-and hyperglycemia. The condition is often underdiagnosed despite its notable prevalence in patients with pancreatic disease, including malignancy and post-surgical states. Clinically, it overlaps with type 1 and type 2 diabetes but is distinguished by malabsorption and weight loss. Diagnosis requires standard glycemic criteria alongside evidence of pancreatic pathology and exclusion of other diabetes types. Management combines lifestyle measures, pancreatic enzyme replacement, and primarily insulin therapy, with metformin in selected cases. Early recognition is crucial due to its association with pancreatic cancer and increased risk of microvascular complications.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"318-322"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing Diamond for Gold: Our New Editorial Policy. 改钻石为黄金：我们的新编辑政策。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7565
Editorial Team Of Journal Of Gastrointestinal And Liver Diseases
{"title":"Changing Diamond for Gold: Our New Editorial Policy.","authors":"Editorial Team Of Journal Of Gastrointestinal And Liver Diseases","doi":"10.15403/jgld-7565","DOIUrl":"https://doi.org/10.15403/jgld-7565","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"313"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: "A Pilot Real-life Study Opioid Induced Constipation in Neoplastic Patients Admitted to Internal Medicine Ward. Outcome of Naldemedine Therapy According to Available Guidelines": the importance of gastrointestinal screening before naldemedine. 评论：“在内科病房住院的肿瘤患者中阿片类药物引起便秘的一项试点现实研究。”根据现有指南纳地美定治疗的结果：纳地美定用药前胃肠筛查的重要性。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7564
Yukai Chen, Qi Lin
{"title":"Comment on: \"A Pilot Real-life Study Opioid Induced Constipation in Neoplastic Patients Admitted to Internal Medicine Ward. Outcome of Naldemedine Therapy According to Available Guidelines\": the importance of gastrointestinal screening before naldemedine.","authors":"Yukai Chen, Qi Lin","doi":"10.15403/jgld-7564","DOIUrl":"https://doi.org/10.15403/jgld-7564","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"492"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residual risk after SVR in advanced hepatitis C fibrosis: five-year real-world outcomes. 晚期丙型肝炎纤维化SVR后的剩余风险：5年真实结果
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6949
Rosélia Lima, Maria Rui Gomes, Renata Maçano, Carla Fagundes, Margarida Mota
{"title":"Residual risk after SVR in advanced hepatitis C fibrosis: five-year real-world outcomes.","authors":"Rosélia Lima, Maria Rui Gomes, Renata Maçano, Carla Fagundes, Margarida Mota","doi":"10.15403/jgld-6949","DOIUrl":"https://doi.org/10.15403/jgld-6949","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"498-499"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methotrexate-induced liver injury or acute hepatitis C flare? The indispensable role of liver biopsy in ambiguous acute liver injury. 甲氨蝶呤引起的肝损伤还是急性丙型肝炎？肝活检在不明性急性肝损伤中不可或缺的作用。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6892
Abdulrahman Ismaiel, Liliana Rogojan, Adriana Albu, Dan L Dumitrascu
{"title":"Methotrexate-induced liver injury or acute hepatitis C flare? The indispensable role of liver biopsy in ambiguous acute liver injury.","authors":"Abdulrahman Ismaiel, Liliana Rogojan, Adriana Albu, Dan L Dumitrascu","doi":"10.15403/jgld-6892","DOIUrl":"https://doi.org/10.15403/jgld-6892","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"497-498"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-7675
Xiaowen Qin, Zhenjing Jin
{"title":"Erratum.","authors":"Xiaowen Qin, Zhenjing Jin","doi":"10.15403/jgld-7675","DOIUrl":"10.15403/jgld-7675","url":null,"abstract":"<p><p>Erratum for: Progress and Perspectives in Overlapping Primary Biliary Cholangitis and Autoimmune Hepatitis: A Comprehensive Review. J Gastrointestin Liver Dis. 2025;34:241-249 PMID: 40580520 DOI: 10.15403/jgld-6138.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"505"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empirical anti-TNF dose intensification in inflammatory bowel disease: real-world outcomes from a resource-limited setting. 炎症性肠病的经验性抗tnf剂量强化：来自资源有限环境的现实世界结果
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6950
Alex Arenas, Diego Ruedi, Gustavo Walsen, Patricio Ibañez
{"title":"Empirical anti-TNF dose intensification in inflammatory bowel disease: real-world outcomes from a resource-limited setting.","authors":"Alex Arenas, Diego Ruedi, Gustavo Walsen, Patricio Ibañez","doi":"10.15403/jgld-6950","DOIUrl":"https://doi.org/10.15403/jgld-6950","url":null,"abstract":"","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"499-500"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of GLP-1 Receptor Agonist Therapy after Liver Transplantation in Patients with Type 2 Diabetes: A Real-World Cohort Study. GLP-1受体激动剂治疗2型糖尿病患者肝移植后的结果：一项真实世界队列研究
IF 2
Journal of gastrointestinal and liver diseases : JGLD Pub Date : 2026-09-26 DOI: 10.15403/jgld-6863
Guy Loic Nguefang, Sarpong Boateng, Solomon Gyabaah, Joel Gabin Konlack, Yussif Issaka, Edgar Luna Landa, Tracy Chukwu, Elvis Eze, Basile Njei
{"title":"Outcomes of GLP-1 Receptor Agonist Therapy after Liver Transplantation in Patients with Type 2 Diabetes: A Real-World Cohort Study.","authors":"Guy Loic Nguefang, Sarpong Boateng, Solomon Gyabaah, Joel Gabin Konlack, Yussif Issaka, Edgar Luna Landa, Tracy Chukwu, Elvis Eze, Basile Njei","doi":"10.15403/jgld-6863","DOIUrl":"https://doi.org/10.15403/jgld-6863","url":null,"abstract":"<p><strong>Background and aims: </strong>Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used to manage type 2 diabetes mellitus (T2DM) in liver transplant (LT) recipients, but their impact on graft outcomes remains unclear. This study evaluated clinical and graft-related outcomes associated with GLP-1 RA therapy.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using the TriNetX Network, identifying adults with LT and T2DM. Two cohorts were defined: LT recipients treated with GLP-1 RAs and those receiving conventional antidiabetic therapy. Propensity score matching (1:1) was applied based on demographics, comorbidities, and immunosuppressive regimens. The index date was the first GLP-1 RA prescription within six months before or after LT. Outcomes assessed at one year included all-cause mortality, graft rejection, graft failure, biliary stricture, hepatic artery thrombosis, and transplant-related infections. Analyses used Kaplan-Meier survival curves and Cox proportional hazards models.</p><p><strong>Results: </strong>After matching, 704 patients were included in each cohort. GLP-1 RA use was associated with significantly lower mortality (4.2% vs. 12.6%; HR=0.33, 95%CI: 0.22-0.50; p<0.0001) and reduced risks of rejection (9.0% vs. 15.5%; HR=0.55; p=0.0008), graft failure (7.1% vs. 13.8%; HR=0.50; p=0.0002), biliary stricture (4.1% vs. 6.7%; HR=0.60; p=0.0342), infections (5.7% vs. 10.1%; HR=0.54; p=0.0032), and hepatic artery thrombosis (5.4% vs. 10.7%; HR=0.48; p=0.0007).</p><p><strong>Conclusions: </strong>GLP-1 RA therapy was associated with improved survival and lower rates of major post-transplant complications, suggesting a potential role as preferred antidiabetic therapy in LT recipients with T2DM.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"35 3","pages":"407-413"},"PeriodicalIF":2.0,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149070866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书